Conferencia de Consenso sobre el ganglio centinela en el cáncer de mama

Burnstein HJ, Winer EP. Primary care for survivors of breast cancer. N Engl J Med 2000;343:1086–94.

Krag D, Weaber D, Ashikaga T, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 1998;339:941–6.

Rull M, Fraile M, Julian FJ, et al. Resultado de la biopsia del ganglio centinela en 100 pacientes con cáncer de mama. Rev Senología y Patol Mam 2000;13 (1):16–22.

Gray RI, Giuliano R, Danway EL, et al. Radioguiance for non palpable primary lesions and sentinel lymph node (s). Am J Surg 2001;182:404–6.

Dupont E, Cox CE, Nguyenk K, et al. Utility of internal mammary lymph node removal when noted by intraoperative gamma probe detection. Ann Surg Oncol 2001; 8:833–6.

Cox CE. Lymphatic mapping in breast cancer: combination technique. Am Surg Oncol 2001;8(9 Suppl):67S-70.

Schirrmeister H, Kühn T, Guhlman A, et al. Fluorine-18-2-deoxi-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures. Eur J Nucl Med 2001;28:351–8.

Beitsch PD, Clifford E, Whitworth P, et al. Improved lymphatic mapping technique for breast cancer. Breast J 2001;7:219–23.

Viale G, Bosari S, Mazzarol G, et al. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 1999;85:2433–8.

Ludwig Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 1990;33:1565–8.